Company Filing History:
2 out of 270 
1 out of 242 
Years Active: 2015-2021
Title: Herve Luche: Innovator in Gene Targeting Technologies
Introduction
Herve Luche is a prominent inventor based in Ulm, Germany. He has made significant contributions to the field of genetic engineering, particularly in the area of gene targeting technologies. With a total of 3 patents, his work has the potential to impact various applications in biotechnology and medicine.
Latest Patents
One of his latest patents is focused on a vector for targeting the human Rosa26 gene. This invention provides a method for generating a transgenic eukaryotic cell population with a modified human Rosa26 locus. The method includes introducing a functional DNA sequence into the human Rosa26 locus of starting eukaryotic cells. Additionally, the patent outlines targeting vectors useful in this method, as well as a cell population and a transgenic non-human animal comprising a modified human Rosa26 locus. Furthermore, it provides an isolated DNA sequence corresponding to the human Rosa26 locus. Another significant patent by Luche is related to stem cell gene targeting, which shares similar methodologies and applications as his work on the Rosa26 gene.
Career Highlights
Herve Luche has worked with esteemed institutions such as the Icahn School of Medicine at Mount Sinai and the Mount Sinai School of Medicine. His experience in these prestigious organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Throughout his career, Luche has collaborated with notable colleagues, including Gordon Keller and Stefan Irion. These partnerships have further enriched his research and innovation in the field of genetic engineering.
Conclusion
Herve Luche's contributions to gene targeting technologies exemplify the innovative spirit of modern science. His patents and collaborations highlight the importance of genetic research in advancing medical and biotechnological applications.